WO2016173383A1 - 一次性安全胰岛素注射针头 - Google Patents

一次性安全胰岛素注射针头 Download PDF

Info

Publication number
WO2016173383A1
WO2016173383A1 PCT/CN2016/078193 CN2016078193W WO2016173383A1 WO 2016173383 A1 WO2016173383 A1 WO 2016173383A1 CN 2016078193 W CN2016078193 W CN 2016078193W WO 2016173383 A1 WO2016173383 A1 WO 2016173383A1
Authority
WO
WIPO (PCT)
Prior art keywords
seat
needle
main casing
positioning
outer sheath
Prior art date
Application number
PCT/CN2016/078193
Other languages
English (en)
French (fr)
Inventor
施国平
霍斯特曼安东尼·斯科特
Original Assignee
苏州施莱医疗器械有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 苏州施莱医疗器械有限公司 filed Critical 苏州施莱医疗器械有限公司
Publication of WO2016173383A1 publication Critical patent/WO2016173383A1/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
    • A61M5/321—Means for protection against accidental injuries by used needles
    • A61M5/3243—Means for protection against accidental injuries by used needles being axially-extensible, e.g. protective sleeves coaxially slidable on the syringe barrel
    • A61M5/3257—Semi-automatic sleeve extension, i.e. in which triggering of the sleeve extension requires a deliberate action by the user, e.g. manual release of spring-biased extension means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/34—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/34—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub
    • A61M5/348—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub snap lock, i.e. upon axial displacement of needle assembly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
    • A61M5/321—Means for protection against accidental injuries by used needles
    • A61M5/3243—Means for protection against accidental injuries by used needles being axially-extensible, e.g. protective sleeves coaxially slidable on the syringe barrel
    • A61M5/326—Fully automatic sleeve extension, i.e. in which triggering of the sleeve does not require a deliberate action by the user
    • A61M2005/3261—Fully automatic sleeve extension, i.e. in which triggering of the sleeve does not require a deliberate action by the user triggered by radial deflection of the anchoring parts between sleeve and syringe barrel, e.g. spreading of sleeve retaining hooks having slanted surfaces by engagement with conically shaped collet of the piston rod during the last portion of the injection stroke of the plunger
    • A61M2005/3263—Trigger provided at the distal end, i.e. syringe end for mounting a needle

Definitions

  • the present invention relates to a medical insulin injection tool, and more particularly to a disposable insulin injection needle.
  • a medical insulin injection tool and more particularly to a disposable insulin injection needle.
  • Such an injection needle can be used with an insulin pen for self-administration or other administration, wherein the insulin pen can be reused and the injection needle is a single-use needle.
  • Diabetes is a metabolic disease characterized by hyperglycemia. There is no cure at present, but injecting insulin into patients can effectively control the disease.
  • the insulin injection needle of the present invention is an injection tool for use with an insulin pen, wherein the insulin pen carries a prescribed amount of insulin liquid medicine, which can be reused, and the injection needle is a kind. Disposable needle with safety device.
  • a needle body for injecting insulin and a needle holder for fixing the needle body
  • a main housing for connecting to an insulin pen
  • the needle body is fixed on the needle seat, the injection section of the needle body protrudes from the front end of the needle seat, and the connecting section of the needle body protrudes from the rear end of the needle seat, but the needle seat is fixed relative to the main casing
  • the connection relationship the advantage of this design is that the structure is simple, and the invention improves the connection relationship from another angle to reflect the safety and convenience of the use of the injection needle.
  • the present invention provides a disposable safety insulin injection needle whose purpose is to solve the safety and convenience problems in the prior art use described above.
  • a disposable safety insulin injection needle comprising:
  • a needle body having an injection section extending toward the front end, a connecting section extending toward the rear end direction, and a fixing section between the injection section and the connecting section;
  • a needle seat for fixing the needle body, the fixed section of the needle body is fixed on the needle seat, and the injection section of the needle body is from the front end of the needle seat Extending, the connecting portion of the needle body protrudes from the rear end of the needle seat;
  • the main housing is a cylindrical structure, in the assembled state, the needle seat and the needle body are located in the main housing (3), and the rear end of the main housing is used for connecting the insulin pen;
  • the main structure of the trigger tube is a tube body, and the trigger tube is located in the front end of the main housing and extends outside the front end in the assembled state before use, for protecting the injection section of the needle body;
  • the needle seat is composed of a seat plate and a seat bar.
  • the seat bar is located at the front end of the seat plate and is fixedly connected with the seat plate; the outer edge of the seat plate is matched with the inner edge of the main casing, and the outer edge of the corresponding seat plate is at the inner edge of the main casing.
  • the upper axial position is provided with a first positioning position and a second positioning position.
  • the axial thrust generated by the insulin pen head on the needle seat forces the seat plate to be in the main Moving from the first positioning position to the second positioning position in the axial direction, so that the needle seat and the main housing form a sliding positioning connection relationship; in the first positioning position, the outer edge of the seat plate and the main housing The inner edge is matched by the first positioning structure, and the outer edge of the seat plate and the inner edge of the main casing are matched by the second positioning structure in the second positioning position; the first positioning structure adopts a concave-convex positioning structure and an elastic positioning structure Or a friction positioning structure; the second positioning structure adopts a concave-convex positioning structure, an elastic positioning structure, a friction positioning structure, a card locking position structure or an end surface abutting positioning structure;
  • the trigger tube is provided with a limit for moving forward relative to the main housing, and the rear portion of the trigger tube is sleeved on the seat post of the needle seat; the side between the trigger tube body and the seat post is provided with a concave portion, and the other side is provided a convex portion, the concave portion is stuck on the convex portion to form a third positioning.
  • the trigger tube is in the third positioning position relative to the seat rod
  • the seat plate on the needle seat is in the first positioning position relative to the main housing; when the seat plate is in the main housing
  • the trigger tube and the seat post release the third positioning and form a sliding connection.
  • the "front” in the “front end”, “forward”, “front and rear”, “front”, “front”, “front end” refers to the disposable safe insulin of the present invention.
  • the “back” in the “back end”, “front and rear”, “backward”, “rear”, and “rear” refers to the opposite direction of "front”.
  • the outer casing is provided with an outer sheath, and the outer sheath is a sleeve structure.
  • the outer sheath is sleeved on the outer side of the main casing in an assembled state before use, for protecting the whole needle.
  • the limiting position of the trigger tube relative to the main housing for moving forward is formed by the front end of the trigger tube approaching or abutting against the front inner end surface of the outer sheath.
  • the concave-convex positioning structure is formed by a groove provided in a circumferential direction of the outer edge of the seat plate and a convex rib provided on the inner edge of the main casing.
  • the elastic positioning structure is formed by the elastic bead pin and the recess, and one of the elastic bead pin and the recess is disposed on the outer edge of the seat pan, and the other is disposed on the inner edge of the main casing.
  • the friction positioning structure is formed by frictional engagement between the outer edge of the seat plate and the inner edge of the main housing.
  • the card locking position structure is formed by the outer edge of the seat plate and the front and rear end faces being engaged with the card slots provided on the inner edge of the main casing.
  • the end face abutment positioning structure is formed by abutting the front end surface of the outer edge of the seat plate against the inner end surface of the inner edge of the main casing.
  • the side wall of the main casing cylinder is provided with a bayonet, and the bayonet is located at a second positioning position in the axial direction of the main casing, and the bayonet is a passage through the inner wall of the main casing.
  • the hole corresponding to the through hole is provided with a block on the inner wall of the outer sheath sleeve, and the card block is inserted into the bayonet and protrudes into the main casing in the state of the outer sheath set main casing, so that the outer sheath is lockedly connected with the main casing
  • the seat plate moves from the first positioning position to the second positioning position, the outer edge of the seat plate pushes up the block on the outer sheath, so that the outer sheath is deformed, and finally the block and the bayonet are buckled, thereby achieving the outer
  • the sheath is unlocked from the main housing, and in this state, the outer sheath is allowed to be removed.
  • an inwardly protruding rib may be arranged on the inner wall of the sleeve of the outer sheath, and the outer sheath is set in the main casing. After the outer side, a gap is provided between the inner wall of the outer sheath and the outer wall of the main casing for deformation of the outer sheath.
  • a slot extending toward the front end may be provided at the bayonet of the main casing to facilitate the card and the card. The mouth is separated.
  • the design principle and effect of the present invention are:
  • the present invention relates to a disposable safety insulin injection needle that needs to be used in conjunction with an insulin pen, the technical idea of which is:
  • a third positioning structure formed by the concave-convex structure is disposed between the trigger tube body and the seat post, and the reliability problem of the triggering needle protecting the needle injection section before and during use is solved, and the trigger tube is ensured before use and In use, the safety of the needle injection section is effectively protected;
  • connection between the needle holder for fixing the needle body and the main housing is designed to be slidingly positioned, that is, the axial thrust of the needle holder is forced by the insulin pen head when the injection needle is mounted, and the seat on the needle holder is forced. Stopping the disk from the first positioning position to the second positioning position, thereby associating the information of whether the injection needle is in place with the moving position of the seat disk on the needle seat in the main housing;
  • the present invention rationally utilizes the axial thrust and position of the injection needle to achieve automatic unlocking of the trigger tube. Its technical concept is clever, the design scheme is reasonable, with outstanding substantive features and significant technological progress, fully reflecting the safety and convenience of the use of injection needles.
  • FIG. 1 is a perspective view of a disposable safety insulin injection needle according to an embodiment of the present invention.
  • FIG. 2 is an exploded perspective view of a disposable safety insulin injection needle according to an embodiment of the present invention
  • Figure 3 is a perspective view of a tail cap according to an embodiment of the present invention.
  • Figure 4 is a perspective view of a needle holder and a needle body according to an embodiment of the present invention.
  • Figure 5 is a perspective view, partly in section, of the main casing of the embodiment of the present invention.
  • Figure 6 is a perspective view of a front sleeve of an embodiment of the present invention.
  • Figure 7 is a perspective view, partly in section, of the front sleeve of the embodiment of the present invention.
  • Figure 8 is a perspective view of a trigger tube according to an embodiment of the present invention.
  • Figure 9 is a perspective view showing a partial cross section of a trigger tube according to an embodiment of the present invention.
  • Figure 10 is a perspective view, partly in section, of an embodiment of the present invention.
  • Figure 11 is an end elevational view of a disposable safety insulin injection needle with an A-A cross-sectional mark in accordance with an embodiment of the present invention
  • Figure 12 is an end elevational view of a disposable safety insulin injection needle with a B-B cross-sectional mark in accordance with an embodiment of the present invention
  • Figure 13 is an end elevational view of a disposable safety insulin injection needle with a C-C cross-sectional mark in accordance with an embodiment of the present invention
  • Figure 14 is a cross-sectional view taken along line A-A of the embodiment before use in the embodiment of the present invention.
  • Figure 15 is a cross-sectional view taken along line C-C of the embodiment before use in the embodiment of the present invention.
  • Figure 16 is a cross-sectional view of the A-A after the tail cover is hidden in the state before use according to the embodiment of the present invention
  • Figure 17 is a cross-sectional view of the A-A of the embodiment of the present invention when the insulin pen is screwed into the injection needle using the first stage;
  • Figure 18 is a cross-sectional view along line A-A of the embodiment of the present invention when the second stage insulin pen is used to continue to be screwed into the injection needle;
  • Figure 19 is a cross-sectional view taken along the line A-A of the embodiment of the present invention when the third stage insulin pen is used to continue to be screwed into the injection needle;
  • Figure 20 is a cross-sectional view taken along line B-B of the embodiment of the present invention when the third stage insulin pen is used to continue to be screwed into the injection needle;
  • Figure 21 is a cross-sectional view taken along line C-C of the embodiment of the present invention when the fourth stage insulin pen is used to continue to be screwed into the injection needle;
  • Figure 22 is a cross-sectional view taken along line A-A of the embodiment of the present invention when the fourth stage insulin pen is used to continue to be screwed into the injection needle;
  • Figure 23 is a cross-sectional view taken along line B-B of the embodiment of the present invention when the fourth stage insulin pen is used to continue to be screwed into the injection needle;
  • Figure 24 is a perspective view showing the fifth stage of the removal of the sheath according to the embodiment of the present invention.
  • Figure 25 is a cross-sectional view along line A-A of the fifth stage of the present invention using the fifth embodiment
  • Figure 26 is a cross-sectional view along line A-A of the embodiment of the present invention when the sixth stage needle is used to start piercing human skin;
  • Figure 27 is a cross-sectional view along line A-A of the embodiment of the present invention when the seventh stage needle is used to penetrate human skin;
  • Figure 28 is a cross-sectional view showing the A-A of the embodiment of the present invention when the eighth stage needle is completely inserted into the human skin and insulin is injected;
  • Figure 29 is a cross-sectional view showing the A-A of the ninth stage after the injection of the insulin needle from the skin is carried out according to an embodiment of the present invention.
  • Figure 30 is a cross-sectional view taken along line B-B of the ninth stage after the injection of the insulin needle from the skin is carried out according to an embodiment of the present invention
  • Figure 31 is a cross-sectional view taken along the line A-A of the embodiment of the present invention when the injection needle is rotated using the tenth stage insulin pen;
  • Figure 32 is a cross-sectional view taken along line A-A of the embodiment of the present invention.
  • Figure 33 is a perspective view of the front sleeve of the present invention for displaying a "station";
  • Figure 34 is a perspective view showing the trigger tube of the present invention as a display "block";
  • Figure 35 is a cross-sectional view taken along line B-B showing the cooperation of the "station” and the "stop”;
  • Figure 36 is a perspective view of an insulin injection needle according to another embodiment of the present invention.
  • Figure 37 is a perspective view of a needle hub in another embodiment of the present invention.
  • Figure 38 is a cross-sectional view taken along the line A-A in a state before use according to another embodiment of the present invention.
  • Figure 39 is a cross-sectional view taken along line B-B of the embodiment before use according to another embodiment of the present invention.
  • Figure 40 is a cross-sectional view along line A-A of the embodiment of the present invention in which the outer sheath is removed;
  • Figure 41 is a cross-sectional view along line B-B of the embodiment of the present invention when the outer sheath is removed;
  • Figure 42 is a cross-sectional view taken along line A-A of the other embodiment of the present invention.
  • Figure 43 is a cross-sectional view taken along line B-B of the embodiment of the present invention in use.
  • tail cover 11. contact hook; 12. bevel; 13. stop; 14. sharp corner; 15. cap; 16. front leg;
  • Needle seat 21. Groove; 22. Convex; 23. Seat; 24. Seatpost;
  • main housing 31. first cassette step; 32. evasion slot; 33. rib; 34. card slot; 35. second card step; 36. anti-back groove; 37. ;38. bayonet; 39. chute;
  • Trigger tube 51. recess; 52. plug; 53.
  • outer sheath 81. card block; 82. ribs.
  • Example 1 Disposable Safe Insulin Injection Needle (with Front Tip Protection and Rear Tip Protection)
  • the injection needle consists of a needle body 6, a needle holder 2, a main housing 3, an outer sheath 8, a tail cap 1, a front sleeve 4, a trigger tube 5, and a spring 7 (see Fig. 2). .
  • the needle body 6 is for injecting an insulin needle, the needle body 6 has an injection section extending toward the front end, a connecting section extending toward the rear end direction, and a fixed section between the injection section and the connecting section. .
  • the needle holder 2 is used for fixing the needle body 6 (see FIG. 4), and the fixing portion of the needle body 6 is fixed on the needle holder 2.
  • the injection section of the needle body 6 protrudes from the front end of the needle holder 2, and the connecting portion of the needle body 6 Extending from the rear end of the hub 2.
  • the needle seat 2 is composed of a seat pan 23 and a seat post 24.
  • the seat post 24 is located at the front end of the seat pan 23 and is fixedly connected with the seat pan 23.
  • the seat post 24 is provided with a convex portion 22, and the seat plate 23 is provided with two retaining slots. 25, a groove 21 is provided in the circumferential direction of the outer edge of the seat pan 23.
  • the main casing 3 is for accommodating the outer casing 8 except for the sheath 8 (see Fig. 5).
  • the main casing 3 has a cylindrical structure in which components such as the hub 2 and the needle 6 are located in the assembled state.
  • a first latching step 31 is disposed in a middle portion of the inner wall of the main housing 3
  • a second latching step 35 is disposed at a front end of the inner wall of the main housing 3
  • a third latching step is disposed at a rear portion of the inner wall of the main housing 3. 37.
  • the front wall of the main casing 3 is provided with an anti-retracting groove 36.
  • the front part of the inner wall of the main casing 3 is further provided with a escaping groove 32.
  • the inner edge of the main casing 3 is provided with a rib 33 and a card slot 34.
  • the rib 33 is located at a first positioning position of the main housing 3 in the axial direction
  • the slot 34 is located at a second positioning position of the main housing 3 in the axial direction. If the rear end of the main housing 3 is used as a reference, the first positioning position is to the main position.
  • the distance of the rear end of the housing 3 is smaller than the distance from the second positioning position to the rear end of the main housing 3.
  • the side wall of the main casing 3 is provided with a bayonet 38.
  • the bayonet 38 is axially located at a second positioning position of the main casing 3, and the bayonet 38 is a through hole extending through the inner and outer walls of the main casing 3.
  • the bayonet 38 is provided with a sliding slot 39 extending in the direction of the front end (to facilitate the separation of the latch 81 from the bayonet 38).
  • the rear end of the main casing 3 is used for connecting an insulin pen, and the connection structure may be a screw connection method, a plug connection method, a plug-and-spin rotation connection method, or the like.
  • the main housing 3 of Fig. 5 shows a threaded connection.
  • the outer sheath 8 is used to protect the entire injection needle (see Figure 10).
  • the outer sheath 8 is of a sleeve structure, and the outer sheath 8 is fitted outside the main casing 3 in an assembled state before use.
  • the inner wall of the sleeve of the outer sheath 8 is provided with a latching block 81.
  • the latching block 81 corresponds in position to the bayonet 38 on the side wall of the tubular body of the main casing 3, and the latching block 81 is in the state of the outer sheath 8 in the state of the main casing 3.
  • the card insertion opening 38 extends into the main casing 3 to lock the outer casing 8 to the main casing 3.
  • the inner wall of the sleeve of the outer sheath 8 is provided with an inwardly projecting rib 82 in the axial direction.
  • the tail cap 1 is used to protect the connecting section of the needle body 6 (see Fig. 3).
  • the tail cap 1 is composed of a cap 15 and two front legs 16.
  • the cap 15 is an end cap or an annular body.
  • the center of the cap 15 is provided with a pinhole hole 17 for inserting only the connecting portion of the needle body 6, and the pinhole 17 is axially Parallel to the axis of the main casing 3,
  • the two front legs 16 are fixedly coupled to the front end of the cap 15, and are symmetrically arranged with respect to the axis of the pinhole 17, and the inner side of each of the front legs 16 is provided with a slope 12 at the root position.
  • the central portion is provided with an inwardly extending stopper 13 and a contact hook 11 at the end position; and the outer side of each of the front legs 16 is provided with a pointed latch 14 at a central position.
  • the front sleeve 4 is used to protect the injection section of the needle body 6 after use (see Figures 6 and 7).
  • the main structure of the front sleeve 4 is a tubular body, and the front end of the front sleeve 4 is provided with an inner end surface 44; the rear end of the front sleeve 4 is provided with a resilient latch 41 extending rearward and an elastic tail 43 extending rearward.
  • the elastic latch 41 and the elastic tail 43 are circumferentially staggered in the front sleeve 4; the outer side of the front sleeve 4 is provided with an outwardly extending projection 42, and the projection 42 and the elastic latch 41 are circumferentially of the front sleeve 4.
  • the projection 42 is provided with an inclined surface 45 on the side of the elastic latch 41.
  • the trigger tube 5 is used to protect the injection section of the needle body 6 (see Figs. 8 and 9).
  • the main structure of the trigger tube 5 is a tube body.
  • the rear end of the trigger tube 5 is provided with two plugs 52 extending rearward.
  • the plug 52 is provided with a barb, and the trigger tube 5 is disposed in the recess 51.
  • the spring 7 is used to push the front sleeve 4 and the tail cap 1.
  • a third positioning structure formed by the concave-convex structure is disposed between the trigger tube 5 and the seat post 24. That is, a recess 51 is provided on the side between the trigger tube 5 and the seat post 24, and the other side is provided with a convex portion 22, and the recess 51 is caught on the convex portion 22 to form a third position.
  • the structural feature solves the problem of solving the reliability problem of the triggering tube 5 protecting the injection section of the needle body 6 before and during use, and ensuring that the trigger tube 5 is effectively protected against the safety of the injection section of the needle body 6 before use and during use.
  • the needle holder 2 for fixing the needle body 6 and the main casing 3 are designed to be in a slidingly positioned connection relationship. That is, the outer edge of the upper seat pan 23 of the needle seat 2 cooperates with the inner edge of the main casing 3, and the outer edge of the corresponding seat plate 23 is axially spaced apart from the inner edge of the main casing 3 to be provided with a first positioning position and a second positioning position.
  • the axial thrust generated by the insulin pen head on the needle hub 2 forces the seat pan 23 to axially forward from the first positioning position within the main casing 3. Moving to the second positioning position, the needle seat 2 and the main housing 3 form a sliding positioning connection relationship.
  • the first positioning structure is a concave-convex positioning structure
  • the concave-convex positioning structure is specifically formed by a groove 21 provided in the circumferential direction of the outer edge of the seat plate 23 and a convex rib 33 provided on the inner edge of the main casing 3.
  • the second positioning structure is a card locking position structure.
  • the card locking position structure is specifically formed by the outer edge of the seat plate 23 and the front and rear side end faces being engaged with the card slots 34 provided on the inner edge of the main casing 3.
  • connection relationship is to utilize the axial thrust of the insulin pen head against the needle hub 2 when the injection needle is mounted, forcing the seat pan 23 on the needle hub 2 to move forward from the first positioning position to the second positioning position.
  • the information of stopping, thereby mounting the injection needle in position is associated with the position of movement of the seat pan 23 on the hub 2 within the main housing 3.
  • Corresponding positional relationship is established between the third positioning position and the first positioning position.
  • the trigger tube 5 When the trigger tube 5 is in the third positioning position relative to the seat post 24, the seat pan 23 on the hub 2 is in a first positioning position relative to the main housing 3; when the seat pan 23 is in the main housing 3 from the first positioning position
  • the trigger tube 5 and the seat post 24 are disengaged from the third position and form a sliding connection.
  • the positional relationship feature associates the information of whether the injection needle is in place through the movement position of the seat disk in the main housing and whether the trigger tube is unlocked after positioning, and finally triggers whether the tube is positioned to unlock and whether the insulin pen and the injection needle are prepared.
  • the state of good injection is linked, which greatly improves the safety and convenience of the use of the injection needle.
  • the outer sheath 8 in the assembled state before use, the outer sheath 8 is fitted outside the main casing 3, and the block 81 on the outer sheath 8 is snapped into the bayonet 38 of the main casing 3 and extends into the main In the casing 3, the outer sheath 8 is lockedly connected with the main casing 3; the needle seat 2 and the needle body 6 are located in the main casing 3, and the seat pan 23 on the needle seat 2 is in the first positioning position in the main casing 3. In the first positioning position, the groove 21 in the circumferential direction of the outer edge of the seat plate 23 cooperates with the rib 33 on the inner edge of the main casing 3 to form a concave-convex positioning structure (see FIG.
  • the tail cover 1 is located at the rear end of the main casing 3. Inside, the cap 15 on the tail cap 1 is located behind the seat pan 23 for protecting the connecting section of the needle body 6 (see Figs. 14 and 15), and the two front legs 16 on the tail cap 1 pass through two of the seat pans 23
  • the retaining groove 25 is extended forward (see FIGS. 14 and 15); the front sleeve 4 is located in the main casing 3, and the elastic latch 41 on the front sleeve 4 is firstly caught on the main casing 3. On the step 31, the front sleeve 4 is restricted from moving forward relative to the main casing 3 (see FIG.
  • the trigger tube 5 is located in the front end of the main casing 3 and extends outside the front end.
  • the rear portion of the trigger tube 5 is fitted on the seat post 24 of the needle holder 2, and the rear portion of the trigger tube 5 is located in the front sleeve 4, and the front end of the trigger tube 5 is approached.
  • the recess 51 on the trigger tube 5 is caught on the convex portion 22 of the seat post 24 to form a position (see Figs. 15 and 16); the spring 7 is abutted against the tail cover at one end.
  • the two front legs 16 are on the stop 13 and the other end abuts against the inner end face 44 of the front sleeve 4 (see Figure 14).
  • the first stage is a first stage
  • Figure 17 shows the state of the first phase.
  • the user screwes the insulin pen head into the injection needle of this embodiment.
  • the head of the insulin pen pushes the tail cap 1 forward, and the arrow in Fig. 17 indicates the thrust generated by the head of the insulin pen, while the contact hook 11 of the tail cap 1 is topped by the inclined surface 45 on the projection 42 of the front sleeve 4.
  • Figure 18 shows the state of the second phase. As can be seen from Fig. 18, in this state, the insulin pen continues to be screwed into the injection needle, and the contact hook 11 of the tail cap 1 passes over the projection 42 of the front sleeve 4, while the inclined surface 12 of the tail cover 1 presses the front sleeve 4 Bomb on The sex cassette 41 is bent inward.
  • the third stage is the third stage.
  • the latch 81 on the outer sheath 8 snaps into the bayonet 38 of the main casing 3 and projects into the main casing 3, and the dial 23 on the hub 2 remains In the first positioning position, the tail cap 1 gradually contacts the seat pan 23 on the needle hub 2.
  • 21, 22, and 23 show the state of the fourth stage.
  • the insulin pen continues to be screwed into the injection needle, and the cap 15 on the tail cap 1 abuts against the seat pan 23 of the hub 2 and pushes the seat pan 23 forward from the first positioning position to the second positioning position (see FIG. 21), in the second positioning position, the outer edge of the seat pan 23 and the front and rear end faces are engaged in the card slot 34 on the inner edge of the main casing 3 to form a card locking position structure, and the seat pan 23 is locked in the second positioning position. You can't move forward or move backwards.
  • 25 and 26 show the state of the fifth stage. In this state, the outer sheath 8 is removed by hand.
  • Fig. 26 shows the state of the sixth stage.
  • the trigger tube 5 is brought into contact with human skin, and the needle body 6 starts to penetrate into the human skin.
  • the trigger tube 5 moves backward, at which time the plug 52 on the trigger tube 5 lifts up the stopper 13 on the tail cover 1, forcing the contact hook 11 of the tail cover 1 and the front
  • the projections 42 of the sleeve 4 are gradually separated.
  • the seventh stage is the seventh stage.
  • Fig. 27 shows the state of the seventh stage.
  • the trigger tube 5 continues to move backward until the contact hook 11 is completely separated from the projection 42 and the front sleeve 4 is moved forward by the spring 7 and protrudes from the front end of the main casing 3, the front sleeve The front end surface of the tube 4 is blocked by the human skin, flushes with the front end surface of the trigger tube 5 and moves together.
  • Fig. 28 shows the state of the eighth stage. In this state, the needle 6 is completely injected into the human skin and begins to inject insulin.
  • the ninth stage is the eighth stage.
  • 29 and 30 show the state of the ninth stage.
  • the injection needle is pulled out from the human skin, at which time the front sleeve 4 is pushed out of the front end of the main casing 3 by the spring 7 until the projection 42 on the front sleeve 4 is second by the main casing 3.
  • Card The step 35 intercepts and stops extending forward, at which time the front sleeve 4 serves to protect the injection section of the needle 6 (see Figure 29).
  • the elastic tail 43 of the front sleeve 4 is extended and then snapped into the anti-retraction groove 36 of the main casing 3 to form a limit for the rear sleeve 4 to move backward, preventing the front sleeve 4 from retreating (see FIG. 30). ).
  • Fig. 31 shows the state of the tenth stage.
  • the insulin pen is screwed out of the injection needle, and the tail cap 1 is moved backward by the spring 7, while the two stoppers 13 on the tail cap 1 clamp the plug 52 on the trigger tube 5, and trigger the trigger.
  • the tube 5 moves backward.
  • Fig. 32 shows the state after use.
  • the trigger tube 5 continues to move backward until the front end of the seat post 24 on the needle hub 2 is lowered by the front inner end surface of the trigger tube 5 to stop.
  • the pointed latch 14 on the tail cover 1 falls into the third latching step 37 of the main housing 3 to form a limit for the forward movement of the tail cap 1, and the barb and the two stoppers of the plug 5 of the triggering tube 5 are triggered.
  • the latch 81 of the outer sheath 8 cooperates with the bayonet 38 of the main casing 3 for locking the outer sheath 8 and the main casing 3;
  • the elastic latch 41 of the front sleeve 4 cooperates with the first latching step 31 of the main housing 3 for limiting the forward movement of the front sleeve 4 within the main housing 3;
  • the elastic latch 41 of the front sleeve 4 cooperates with the contact hook 11 of the tail cover 1 for limiting the rearward movement of the tail cover 1 relative to the front sleeve 4;
  • the inclined surface 12 of the tail cap 1 cooperates with the elastic latch 41 of the front sleeve 4 for releasing the restriction of the forward movement of the front sleeve 4 in the main casing 3. Specifically, in use, as the tail cap 1 moves forward, the inclined surface 12 presses the elastic latch 41 inwardly, eventually forcing the elastic latch 41 to be unhooked from the first latching step 31, releasing the front sleeve 4 in the main casing a limit for forward movement within the body 3;
  • the contact hook 11 of the tail cover 1 cooperates with the projection 42 of the front sleeve 4 for limiting the forward movement of the front sleeve 4.
  • the tail cap 1 moves forward, and the contact hook 11 is raised by the slant of the protrusion 42 and then passes over the protrusion 42 and is in the elastic cassette 41 and the After the hook step 31 is unhooked, the contact hook 11 hooks the protrusion 42 to limit the forward movement of the front sleeve 4 (the protrusion 42 is intercepted by the contact hook 11 in the forward movement);
  • the elastic latch 41 of the front sleeve 4 cooperates with the escaping groove 32 of the main casing 3 for avoiding interference of the elastic latch 41 with the spring 7.
  • the elastic latch 41 passes over the first latching step 31 of the main housing 3 and falls into the escaping slot 32 in order to avoid interference of the elastic latch 41 against the spring 7 (to prevent the elastic latch 41 from coming into contact)
  • the spring 7 forms an interference
  • the cap 15 of the tail cap 1 cooperates with the seat pan 23 of the hub 2 for moving positioning. Specifically, in use, as the tail cap 1 moves forward, the cap 15 gradually contacts the seat pan 23, and pushes the seat pan 23 to break off the first position, and continues to move forward until it falls into the second position and cannot be moved again. ;
  • the seat 23 of the needle hub 2, the engagement between the block 81 of the outer sheath 8 and the bayonet 38 of the main casing 3, is used to allow the removal of the sheath 8 and the insulin pen and the injection needle
  • the state of the injection is ready to be associated. Specifically, in use, when the seat pan 23 on the needle hub 2 falls into the card slot 34 on the main casing 3, firstly, it indicates that the injection needle has been officially mounted to the insulin pen head; secondly, outside the seat pan 23 The ribs lift the latches 81 on the outer sheath 8 to deform the outer sheath 8 , and finally the latches 81 on the outer sheath 8 are released from the bayonet 38 on the main casing 3, thereby achieving external protection.
  • the sleeve 8 is unlocked from the main casing 3, and the sheath 8 can be removed at this time; thirdly, since the front end of the trigger tube 5 abuts against the inner end surface of the outer sheath 8, when the needle holder 2 moves forward, the needle holder 2 The positioning between the upper convex portion 22 and the concave portion 51 on the trigger tube 5 is unlocked, indicating that the trigger tube 5 has entered a state that can be triggered;
  • the plug 52 of the trigger tube 5 cooperates with the stopper 13 of the tail cap 1 for releasing the limit of the forward movement of the front sleeve 4. Specifically, when the front end of the trigger tube 5 is in contact with the human skin, the trigger tube 5 moves backward. At this time, the plug 52 on the trigger tube 5 lifts the stopper 13 on the tail cover 1 to force the contact hook of the tail cover 1 11 is gradually separated from the protrusion 42 of the front sleeve 4 until the front sleeve 4 is moved forward by the action of the spring 7 after being completely separated, and protrudes from the front end of the main casing 3, and the front end surface of the front sleeve 4 is blocked by the human body. The skin, flush with the front end surface of the trigger tube 5, and move together until the needle has completely entered the human skin and begins to inject insulin.
  • the projection 42 of the front sleeve 4 cooperates with the second latching step 35 of the main casing 3 for achieving a limit of the front sleeve 4 projecting outward from the main casing 3 (preventing the front sleeve 4 Sliding out of the main casing 3);
  • the elastic tail 43 of the front sleeve 4 cooperates with the anti-retraction groove 36 of the main casing 3 for realizing the limit of the front sleeve 4 retreating inward from the main casing 3 (preventing the front casing 4 from the main Retracting in the housing 3);
  • the tail cap 1 sharp corner latch 14 cooperates with the third latching step 37 of the main casing 3 for preventing the tail cap 1 from being in the main casing 3 Move forward under the action of internal external force to prevent secondary use of the needle.
  • Example 2 Disposable safe insulin injection needle (with front end needle protection without rear end needle protection) As shown in Fig. 36, the injection needle is composed of a needle body 6, a needle holder 2, a main casing 3, and an outer sheath 8. , front sleeve 4, trigger tube 5 and spring 7.
  • Example 2 After fully understanding the insulin injection needle of Example 1, Example 2 has only a front end needle protection structure and no rear end needle protection structure as compared to Example 1. Specifically, there are the following differences in structural design:
  • Embodiment 2 cancels the tail cover 1 in Embodiment 1;
  • the two front legs 16 of the tail cover 1 of the embodiment 1 are transplanted to the needle holder 2 of the embodiment 1, as shown in FIG.
  • Embodiment 2 retains the stopper 13 and the contact hook 11 provided on the front leg 16.
  • the second embodiment eliminates the sharp-angled latches 14 provided on the front legs 16.
  • the third latching step 37 is provided correspondingly to the rear portion of the inner wall of the main casing 3.
  • the outer sheath 8 in the assembled state before use, the outer sheath 8 is fitted outside the main casing 3, and the block 81 on the outer sheath 8 is snapped into the bayonet 38 of the main casing 3 and extends into the main In the casing 3, the outer sheath 8 is lockedly connected with the main casing 3; the needle seat 2 and the needle body 6 are located in the main casing 3, and the seat pan 23 on the needle seat 2 is in the first positioning position in the main casing 3.
  • the groove 21 in the circumferential direction of the outer edge of the seat plate 23 cooperates with the rib 33 on the inner edge of the main casing 3 to form a concave-convex positioning structure, and the two front legs 16 extending forward on the seat plate 23 are extended toward
  • the front sleeve 4 is located in the main casing 3, and the elastic latch 41 on the front sleeve 4 is caught on the first latching step 31 on the main casing 3, and the front sleeve 4 is restrained from the main casing 3 moving forward;
  • the trigger tube 5 is located in the front end of the main housing 3 and extends outside the front end for protecting the injection section of the needle body 6.
  • the trigger tube 5 is provided with a limit for moving forward relative to the main housing 3.
  • the rear portion of the trigger tube 5 is fitted on the seat post 24 of the hub 2, the rear portion of the trigger tube 5 is located in the front sleeve 4, and the trigger tube 5 is in the third positioning position, and the front end of the trigger tube 5 is close to or abutted Inside the front of the sheath 8
  • the recess 51 on the trigger tube 5 is caught on the convex portion 22 of the seat post 24, and the seat 23 on the needle seat 2 is in the first positioning position with respect to the main housing 3; It abuts against the stop 13 of the two front legs 16 of the hub 2 and the other end abuts against the inner end face 44 of the front sleeve 4.
  • the sleeve 4 is moved forward until the projection 42 is intercepted by the contact hook 11 to stop moving and to limit the forward movement of the front sleeve 4; at the same time, the seat 23 is moved forward from the first positioning position to the first position In the second positioning position, the outer edge of the seat pan 23 and the front and rear end faces are engaged in the card slots 34 on the inner edge of the main casing 3 to form a card locking position structure, and the seat plate 23 is locked in the second positioning position. , you can't move forward or move backwards.
  • the trigger tube 5 is brought into contact with the human skin, the needle body 6 begins to penetrate into the human skin, and the trigger tube 5 is moved backward.
  • the plug 52 on the trigger tube 5 pushes up the stopper 13 on the front leg 16, forcing the front leg.
  • the contact hook 11 of the 16 is gradually separated from the projection 42 of the front sleeve 4 until the front sleeve 4 is moved forward by the spring 7 after being completely separated, and protrudes from the front end of the main casing 3, the front sleeve 4
  • the front end face is blocked by the human skin, flushes with the front end surface of the trigger tube 5 and moves together until the needle completely enters the human skin and begins to inject insulin.
  • the front sleeve 4 when the injection needle is withdrawn from the human skin after use, the front sleeve 4 is pushed out of the front end of the main casing 3 by the spring 7 until the projection 42 on the front sleeve 4 is received by the main casing
  • the second latching step 35 on the 3 intercepts and stops extending forward, at which time the front sleeve 4 is used to protect the injection section of the needle body 6; at the same time, the elastic tail fin 43 of the front sleeve 4 is extended and then snapped into the main casing 3
  • the retaining groove 36 forms a limit for the rear sleeve 4 to move backward, prevents the front sleeve 4 from retreating, and finally removes the injection needle from the insulin pen head.
  • the first positioning structure adopts a concave-convex positioning structure, and instead of the elastic positioning structure or the friction positioning structure, the same or similar technical effects can be obtained.
  • the first positioning structure should adopt a non-locking positioning structure because the outer edge of the front seat plate 23 and the inner edge of the main casing 3 are in the first positioning position, and the outer edge of the middle seat plate 23 and the main casing are used. Axial sliding is required between the inner edges of the body 3.
  • the elastic positioning structure is formed by the elastic bead pin and the recess.
  • One of the elastic bead pins and the recess is disposed on the outer edge of the seat pan 23, and the other is disposed on the inner edge of the main casing 3.
  • the friction positioning structure is formed by frictional engagement of the outer edge of the seat plate 23 with the inner edge of the main casing 3.
  • the card positioning structure adopted by the second positioning structure may be replaced by an elastic positioning structure, a friction positioning structure or an end surface abutting positioning structure, and the same or similar may be obtained.
  • the second positioning structure can adopt a non-locking positioning structure, or a locking structure.
  • Elastic positioning structure, friction positioning structure or end face abutment The position structure should belong to a non-locking positioning structure, and in the above embodiment, the card locking position structure formed by the outer edge of the seat plate 23 and the front and rear side end faces and the card slot 34 provided on the inner edge of the main casing 3 should be formed. It is a locking structure with a locking nature.
  • the seat pan 23 can slide back and forth in the card slot 34, thereby converting into Non-locking nature of the positioning structure.
  • the end face abutment positioning structure is formed by the front end surface of the outer edge of the seat plate 23 abutting against the inner end surface of the inner edge of the main casing 3.
  • the bayonet 38 is axially located in the second positioning position of the main housing 3, and the position of the bayonet 38 may be in the second positioning position or the second positioning position.
  • the vicinity refers to a point at the front or a rear side with the second positioning position as a base point.
  • such a positional relationship is set in order to satisfy a specific relationship: when the seat pan 23 is moved from the first positioning position to the second positioning position, the outer edge of the seat plate 23 is raised from the outer sheath.
  • the block 81 on the 8 deforms the outer sheath 8 and finally causes the block 81 to be released from the bayonet 38, thereby unlocking the outer sheath 8 and the main casing 3, and finally whether or not the outer sheath 8 is allowed to be removed.
  • the insulin pen is associated with the state in which the injection needle is ready for injection.
  • the limit of the trigger tube 5 with respect to the main housing 3 for forward movement is formed by the front end of the trigger tube 5 approaching or abutting against the front inner end surface of the outer sheath 8.
  • the stop 53 of the trigger tube 5 abuts against the front inner end surface 44 of the front sleeve 4.
  • the card table 46 is formed with a limit for the forward movement of the trigger tube 5 relative to the main housing 3.
  • the present invention mainly relates to the needle holder 2, the main casing 3,
  • the outer sheath 8 and the trigger tube 5 and their structural and connection relationship are not associated with the tail cap 1, the front sleeve 4 and the spring 7.
  • the tail cap 1, the front sleeve 4 and the spring 7 are non-essential structures for the present invention, allowing them to undergo some changes, for example, eliminating the tail cap 1 for protecting the connecting portion of the needle body 2;
  • the technical solution of the present invention is applied to the Chinese patent CN101563124A introduced in the background art; the technical solution of the present invention is applied to the US patent US2011/0288491A1 and the like.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Environmental & Geological Engineering (AREA)

Abstract

一次性安全胰岛素注射针头，包括针体（6）、针座（2）、主壳体（3）、外护套（8）以及触发管（5）。针座（2）由座盘（23）和座杆（24）固定连接构成，座盘（23）外缘与主壳体（3）内缘具有滑动定位的连接关系，即安装注射针头时利用胰岛素笔头部轴向推力使座盘（23）从第一定位位置移动至第二定位位置，触发管（5）后部套在座杆（24）上，前端顶靠在外护套（8）前部内端面上，触发管（5）与座杆（24）之间设有第三定位结构，当触发管（5）相对座杆（24）处于第三定位位置时，座盘（23）相对主壳体（3）处于第一定位位置上；当座盘（23）在主壳体（3）内从第一定位位置移动至第二定位位置时，触发管（5）与座杆（24）解除第三定位并形成滑动连接。该注射针头将触发管（5）定位后是否解锁与胰岛素笔和注射针头是否准备好注射的状态关联起来，提高了使用的安全性和便利性。

Description

一次性安全胰岛素注射针头 技术领域
本发明涉及医用胰岛素注射工具，特别涉及一种一次性使用的安全胰岛素注射针头。这种注射针头与胰岛素笔配套使用可用于自我给药或他人给药，其中胰岛素笔可重复使用，而注射针头为一次性使用针头。
背景技术
糖尿病是一种以高血糖为特征的代谢性疾病，目前尚无根治的方法，但给患者注射胰岛素可以有效控制病情。
胰岛素的注射工具多种多样，其中本发明所述的胰岛素注射针头是一种与胰岛素笔配套使用的注射工具，其中胰岛素笔携带规定量的胰岛素液体药物，可重复使用，而注射针头为一种带有安全保护装置的一次性使用针头。
中国专利CN101563124A公开了一种名称为《带有远侧和近侧针保护器的针保护装置》的发明专利申请；美国专利US2011/0288491A1公开了一种名称为《安全针组件》的发明专利申请。这两个专利申请均涉及胰岛素注射针头，其基本结构均包括：
1.用于注射胰岛素的针体以及固定针体的针座；
2.用来与胰岛素笔连接的主壳体；
3.用于保护针体使用前后安全的套管；
4.用于移动套管的弹簧；
5.用于保护注射针头整体的外护套，该外护套在上述两件专利的附图中未体现，但在实际产品中可以看到，且通常情况下不可缺少。
上述现有注射针头中，针体固定在针座上，针体的注射段从针座前端伸出，针体的连接段从针座后端伸出，但针座相对主壳体均为固定连接关系，这种设计的优点是结构简单，而本发明从另一角度对其连接关系进行改进，以体现注射针头使用的安全性和便利性。
发明内容
鉴于以上现有技术指出的问题，本发明提供一种一次性安全胰岛素注射针头，其目的是要解决上述现有技术使用中的安全性和便利性问题。
为达到上述目的，本发明采用的技术方案是：一种一次性安全胰岛素注射针头，包括：
针体，该针体具有一个向前端方向延伸的注射段、一个向后端方向延伸的连接段和一个位于注射段和连接段之间的固定段；
针座，该针座用于固定针体，所述针体的固定段固定在针座上，针体的注射段从针座前端 伸出，针体的连接段从针座后端伸出；
主壳体，该主壳体为筒体结构，在装配状态下针座和针体位于主壳体(3)内，主壳体的后端用于连接胰岛素笔；
触发管，该触发管的主体结构为管体，在使用前装配状态下触发管位于主壳体前端内并延伸至前端外，用于保护针体的注射段；
其创新在于：
所述针座由座盘和座杆组成，座杆位于座盘前端并与座盘固定连接；座盘的外缘与主壳体的内缘相配合，对应座盘外缘在主壳体内缘上沿轴向间隔设有第一定位位置和第二定位位置，在所述注射针头安装到所述胰岛素笔的过程中，利用胰岛素笔头部对针座产生的轴向推力迫使座盘在主壳体内从第一定位位置沿轴向向前移动至第二定位位置，从而使针座与主壳体之间形成滑动定位的连接关系；在第一定位位置上座盘的外缘与主壳体的内缘通过第一定位结构进行配合，在第二定位位置上座盘的外缘与主壳体的内缘通过第二定位结构进行配合；所述第一定位结构采用凹凸定位结构、弹性定位结构或者摩擦定位结构；所述第二定位结构采用凹凸定位结构、弹性定位结构、摩擦定位结构、卡锁定位结构或者端面抵靠定位结构；
所述触发管相对主壳体设有向前移动的限位，触发管的后部套装在针座的座杆上；触发管管体与座杆之间一侧设有凹部，另一侧设有凸部，凹部卡在凸部上形成第三定位，当触发管相对座杆处于第三定位位置时，针座上的座盘相对主壳体处于第一定位位置上；当座盘在主壳体内从第一定位位置沿轴向向前移动至第二定位位置时，触发管与座杆解除第三定位，并形成滑动连接。
上述技术方案中的有关内容解释如下：
1.在本发明中，所述“前端”、“向前”、“前后”、“前部”、“前方”、“前端面”中的“前”是指以本发明一次性安全型胰岛素注射针头注射段针尖所指的方向。所述“后端”、“前后”、“向后”、“后部”、“后方”中的“后”是指“前”的反方向。
2.上述方案中，所述主壳体外设有外护套，该外护套为套筒结构，在使用前装配状态下外护套套装在主壳体外侧，用于保护所述注射针头整体；所述触发管相对主壳体设有向前移动的限位由触发管的前端接近或顶靠在外护套的前部内端面上形成。
3.上述方案中，所述凹凸定位结构由设在座盘外缘圆周方向的凹沟与设在主壳体内缘上的凸筋配合形成。
4.上述方案中，所述弹性定位结构由弹性珠销与凹陷配合形成，弹性珠销和凹陷两者中，一者设在座盘外缘上，另一者设在主壳体内缘上。
5.上述方案中，所述摩擦定位结构由座盘外缘与主壳体内缘摩擦配合形成。
6.上述方案中，所述卡锁定位结构由座盘外缘及前后侧端面与主壳体内缘上所设的卡槽配合形成。
7.上述方案中，所述端面抵靠定位结构由座盘外缘的前侧端面与主壳体内缘的内端面抵靠配合形成。
8.上述方案中，所述主壳体筒体侧壁上设有卡口，卡口在主壳体轴向位于第二定位位置上，该卡口为一个贯穿主壳体内外壁之间的通孔，对应该通孔在外护套套筒内壁上设有卡块，在外护套套装主壳体状态下卡块卡入卡口并伸入主壳体内，使外护套与主壳体锁定连接；当座盘从第一定位位置移动至第二定位位置时，座盘外缘顶起外护套上的卡块，使外护套发生变形，最终导致卡块与卡口脱扣，从而实现外护套与主壳体解锁，在此状态下允许摘除外护套。
9.上述方案中，为了有利于外护套与主壳体脱扣解锁，可以在外护套的套筒内壁上沿轴向设有向内突出的筋条，当外护套套装在主壳体外侧后，外护套内壁与主壳体外壁之间留有供外护套发生变形的间隙。
10.上述方案中，为了方便外护套上的卡块脱离主壳体上的卡口，可以在主壳体的卡口处设有向前端方向延伸的滑槽，以有利于卡块与卡口脱离。
本发明设计原理和效果是：本发明涉及一种需要与胰岛素笔配套使用的一次性安全型胰岛素注射针头，其技术构思是：
第一，在触发管管体与座杆之间设有由凹凸结构形成的第三定位结构，解决使用前和使用中触发管保护针体注射段的可靠性问题，保证触发管在使用前和使用中对针体注射段的安全实施有效保护；
第二，将用来固定针体的针座与主壳体之间设计成滑动定位的连接关系，即在安装注射针头时利用胰岛素笔头部对针座的轴向推力迫使针座上的座盘从第一定位位置向前移动至第二定位位置后停止，从而将注射针头是否安装到位的信息与针座上的座盘在主壳体内的移动位置关联起来；
第三，将注射针头是否安装到位的信息通过座盘在主壳体内的移动位置与触发管定位后是否解锁关联起来，最终将触发管定位后是否解锁与胰岛素笔和注射针头是否准备好注射的状态关联起来，从而大大提高了注射针头使用的安全性和便利性。
总之，本发明合理利用了安装注射针头的轴向推力及位置使触发管达到自动解锁的目的。其技术构思巧妙，设计方案合理，具有突出的实质性特点和显著的技术进步，充分体现了注射针头使用的安全性和便利性。
附图说明
附图1为本发明实施例一次性安全胰岛素注射针头的立体图；
附图2为本发明实施例一次性安全胰岛素注射针头的立体分解图；
附图3为本发明实施例尾盖的立体图；
附图4为本发明实施例针座和针体的立体图；
附图5为本发明实施例主壳体带局部剖的立体图；
附图6为本发明实施例前套管的立体图；
附图7为本发明实施例前套管带局部剖的立体图；
附图8为本发明实施例触发管的立体图；
附图9为本发明实施例触发管带局部剖的立体图；
附图10为本发明实施例外护套带局部剖的立体图；
附图11为本发明实施例带A-A剖视标记的一次性安全胰岛素注射针头的端面视图；
附图12为本发明实施例带B-B剖视标记的一次性安全胰岛素注射针头的端面视图；
附图13为本发明实施例带C-C剖视标记的一次性安全胰岛素注射针头的端面视图；
附图14为本发明实施例使用前状态下的A-A剖视图；
附图15为本发明实施例使用前状态下的C-C剖视图；
附图16为本发明实施例使用前状态下隐去尾盖后的A-A剖视图；
附图17为本发明实施例使用第一阶段将胰岛素笔旋入注射针头时的A-A剖视图；
附图18为本发明实施例使用第二阶段胰岛素笔继续旋入注射针头时的A-A剖视图；
附图19为本发明实施例使用第三阶段胰岛素笔继续旋入注射针头时的A-A剖视图；
附图20为本发明实施例使用第三阶段胰岛素笔继续旋入注射针头时的B-B剖视图；
附图21为本发明实施例使用第四阶段胰岛素笔继续旋入注射针头时的C-C剖视图；
附图22为本发明实施例使用第四阶段胰岛素笔继续旋入注射针头时的A-A剖视图；
附图23为本发明实施例使用第四阶段胰岛素笔继续旋入注射针头时的B-B剖视图；
附图24为本发明实施例使用第五阶段摘除外护套时的立体图；
附图25为本发明实施例使用第五阶段摘除外护套时的A-A剖视图；
附图26为本发明实施例使用第六阶段针体开始刺入人体皮肤时的A-A剖视图；
附图27为本发明实施例使用第七阶段针体刺入人体皮肤时的A-A剖视图；
附图28为本发明实施例使用第八阶段针体完全刺入人体皮肤并注射胰岛素时的A-A剖视图；
附图29为本发明实施例使用第九阶段注射完胰岛素针体从皮肤中拔出后时的A-A剖视图；
附图30为本发明实施例使用第九阶段注射完胰岛素针体从皮肤中拔出后时的B-B剖视图；
附图31为本发明实施例使用第十阶段胰岛素笔旋出注射针头时的A-A剖视图；
附图32为本发明实施例使用后状态下的A-A剖视图；
附图33为本发明前套管为显示“卡台”的立体图；
附图34为本发明触发管为显示“挡台”的立体图；
附图35为显示“卡台”与“挡台”配合的B-B剖视图；
附图36为本发明另一实施例胰岛素注射针头的立体图；
附图37为本发明另一实施例中针座的立体图；
附图38为本发明另一实施例使用前状态下的A-A剖视图；
附图39为本发明另一实施例使用前状态下的B-B剖视图；
附图40为本发明另一实施例使用中摘除外护套时的A-A剖视图；
附图41为本发明另一实施例使用中摘除外护套时的B-B剖视图；
附图42为本发明另一实施例使用后状态下的A-A剖视图；
附图43为本发明另一实施例使用后状态下的B-B剖视图。
以上附图中：
1.尾盖；11.触脚钩；12.斜面；13.挡块；14.尖角卡榫；15.盖帽；16.前腿；17.让位孔；
2.针座；21.凹沟；22.凸部；23.座盘；24.座杆；25.让位槽；
3.主壳体；31.第一卡榫台阶；32.规避槽；33.凸筋；34.卡槽；35.第二卡榫台阶；36.防退槽；37.第三卡榫台阶；38.卡口；39.滑槽；
4.前套管；41.弹性卡榫；42.凸起；43.弹性尾翼；44.内端面；45.倾斜面；46.卡台；
5.触发管；51.凹部；52.插头；53.挡台；
6.针体；
7.弹簧；
8.外护套；81.卡块；82.筋条。
具体实施方式
下面结合附图及实施例对本发明作进一步描述：
实施例1：一次性安全胰岛素注射针头(带前端针尖保护和后端针尖保护)
如图1-10所示，该注射针头由针体6、针座2、主壳体3、外护套8、尾盖1、前套管4、触发管5以及弹簧7(见图2)。
下面依次描述本实施例一次性安全胰岛素注射针头的各零部件结构：
1.针体6
所述针体6是一个用于注射胰岛素管针，该针体6具有一个向前端方向延伸的注射段、一个向后端方向延伸的连接段和一个位于注射段和连接段之间的固定段。
2.针座2
所述针座2用于固定针体6(见图4)，针体6的固定段固定在针座2上，针体6的注射段从针座2前端伸出，针体6的连接段从针座2后端伸出。针座2由座盘23和座杆24组成，座杆24位于座盘23前端并与座盘23固定连接，座杆24上设有凸部22，座盘23上设有两个让位槽25，座盘23外缘圆周方向设有凹沟21。
3.主壳体3
所述主壳体3是用来容纳除外护套8而外其他零部件壳体(见图5)。主壳体3为筒体结构，在装配状态下针座2和针体6等零部件位于主壳体3内。主壳体3筒体内壁中部设有第一卡榫台阶31，主壳体3筒体内壁前端设有第二卡榫台阶35，主壳体3筒体内壁后部设有第三卡榫台阶37，主壳体3筒体内壁前部设有防退槽36，主壳体3筒体内壁前部还设有规避槽32，主壳体3内缘上设有凸筋33和卡槽34，凸筋33位于主壳体3轴向的第一定位位置，卡槽34位于主壳体3轴向的第二定位位置，如果以主壳体3后端为基准，第一定位位置至主壳体3后端的距离小于第二定位位置至主壳体3后端的距离。主壳体3筒体侧壁上设有卡口38，卡口38在主壳体3轴向位于第二定位位置上，该卡口38为一个贯穿主壳体3内外壁之间的通孔，卡口38处设有向前端方向延伸的滑槽39(以有利于卡块81与卡口38脱离)。主壳体3的后端用于连接胰岛素笔，其连接结构可以采用螺纹连接方式，也可以采用插拔连接方式，还可以采用插拔旋转扣接方式等等。在本实施例中，图5主壳体3显示的是螺纹连接方式。
4.外护套8
所述外护套8用于保护所述注射针头整体(见图10)。该外护套8为套筒结构，在使用前装配状态下外护套8套装在主壳体3外侧。外护套8套筒内壁上设有卡块81，卡块81在位置上对应主壳体3筒体侧壁上的卡口38，在外护套8套装主壳体3状态下卡块81卡入卡口38并伸入主壳体3内，使外护套8与主壳体3锁定连接。外护套8的套筒内壁上沿轴向设有向内突出的筋条82，当外护套8套装在主壳体3外侧后，外护套8内壁与主壳体3外壁之间留有供外护套8发生变形的间隙。
5.尾盖1
所述尾盖1用于保护针体6的连接段(见图3)。尾盖1由一个盖帽15和两个前腿16组成，盖帽15为端盖或环状体，盖帽15的中央设有仅供针体6连接段穿插的让针孔17，让针孔17轴线与主壳体3轴线平行，两个前腿16固定连接在盖帽15前端上，并且以让针孔17轴线为基准对称布置，每个前腿16的内侧在根部位置上设有斜面12，在中部位置上设有向内延伸的挡块13，在末端位置上设有触脚钩11；每个前腿16的外侧在中部位置上设有尖角卡榫14。
6.前套管4
所述前套管4用于保护使用后针体6的注射段(见图6和图7)。前套管4的主体结构为管体，前套管4的前端内侧设有内端面44；前套管4的后端设有向后延伸的弹性卡榫41和向后延伸的弹性尾翼43，弹性卡榫41与弹性尾翼43在前套管4周向错开布置；前套管4的中部外侧设有向外延伸的凸起42，凸起42和弹性卡榫41在前套管4周向位置对应，凸起42靠弹性卡榫41一侧设有倾斜面45。
7.触发管5
所述触发管5用于保护使用前针体6的注射段(见图8和图9)。触发管5的主体结构为管体，触发管5的后端设有向后延伸的两个插头52，插头52上设有倒钩，触发管5管体内设在凹部51。
8.弹簧7
所述弹簧7用于推压前套管4和尾盖1。
下面描述为解决本发明技术问题所需要的结构、连接关系和位置关系：
1.结构特征
在触发管5管体与座杆24之间设有由凹凸结构形成的第三定位结构。即在触发管5管体与座杆24之间一侧设有凹部51，另一侧设有凸部22，凹部51卡在凸部22上形成第三定位。
总之，该结构特征解决了解决使用前和使用中触发管5保护针体6注射段的可靠性问题，保证触发管5在使用前和使用中对针体6注射段的安全实施有效保护。
2.连接关系特征
将用来固定针体6的针座2与主壳体3之间设计成滑动定位的连接关系。即针座2上座盘23的外缘与主壳体3的内缘相配合，对应座盘23外缘在主壳体3内缘上沿轴向间隔设有第一定位位置和第二定位位置，在所述注射针头安装到所述胰岛素笔的过程中，利用胰岛素笔头部对针座2产生的轴向推力迫使座盘23在主壳体3内从第一定位位置沿轴向向前移动至第二定位位置，从而使针座2与主壳体3之间形成滑动定位的连接关系。
在第一定位位置上座盘23的外缘与主壳体3的内缘通过第一定位结构进行配合，在第二定位位置上座盘23的外缘与主壳体3的内缘通过第二定位结构进行配合。所述第一定位结构为凹凸定位结构，该凹凸定位结构具体由设在座盘23外缘圆周方向的凹沟21与设在主壳体3内缘上的凸筋33配合形成。所述第二定位结构为卡锁定位结构，该卡锁定位结构具体由座盘23外缘及前后侧端面与主壳体3内缘上所设的卡槽34配合形成。
总之，该连接关系特征目的是要在安装注射针头时利用胰岛素笔头部对针座2的轴向推力迫使针座2上的座盘23从第一定位位置向前移动至第二定位位置后停止，从而将注射针头是否安装到位的信息与针座2上的座盘23在主壳体3内的移动位置关联起来。
3.位置关系特征
将第三定位位置与第一定位位置建立对应位置关系。当触发管5相对座杆24处于第三定位位置时，针座2上的座盘23相对主壳体3处于第一定位位置上；当座盘23在主壳体3内从第一定位位置沿轴向向前移动至第二定位位置时，触发管5与座杆24解除第三定位，并形成滑动连接。
总之，该位置关系特征将注射针头是否安装到位的信息通过座盘在主壳体内的移动位置与触发管定位后是否解锁关联起来，最终将触发管定位后是否解锁与胰岛素笔和注射针头是否准备好注射的状态关联起来，从而大大提高了注射针头使用的安全性和便利性。
本实施例一次性安全胰岛素注射针头在使用前装配状态下各零部件的连接关系及位置关系描述如下：
如图14-16所示，在使用前装配状态下，外护套8套装在主壳体3外侧，外护套8上的卡块81卡入主壳体3的卡口38并伸入主壳体3内，使外护套8与主壳体3锁定连接；针座2和针体6位于主壳体3内，针座2上的座盘23处于主壳体3内第一定位位置，在第一定位位置上座盘23外缘圆周方向的凹沟21与主壳体3内缘上的凸筋33配合形成凹凸定位结构(见图15)；尾盖1位于主壳体3后端内，尾盖1上的盖帽15位于座盘23后方用于保护针体6的连接段(见图14和图15)，尾盖1上的两个前腿16穿过座盘23上的两个让位槽25伸向前方(见图14和图15)；所述前套管4位于主壳体3内，前套管4上的弹性卡榫41卡在主壳体3上的第一卡榫台阶31上，限制前套管4相对主壳体3向前运动(见图16)，同时尾盖1两个前腿16上的触脚钩11勾在前套管4的弹性卡榫41上(见图14)；所述触发管5位于主壳体3前端内并延伸至前端外，用于保护针体6的注射段(见图14)，触发管5的后部套装在针座2的座杆24上，触发管5的后部位于前套管4内，触发管5的前端接近或顶靠在外护套8的前部内端面上，触发管5上的凹部51卡在座杆24的凸部22上形成定位(见图15和图16)；所述弹簧7一端抵靠在尾盖1两个前腿16的挡块13上，另一端抵靠在前套管4的内端面44上(见图14)。
本实施例一次性安全胰岛素注射针头的使用过程描述如下：
第一阶段：
图17表示第一阶段的状态。从图17中可以看出，在此状态下，使用者将胰岛素笔头部旋入本实施例所述注射针头。胰岛素笔的头部推动尾盖1向前移动，图17中的箭头表示胰岛素笔头部产生的推力，同时尾盖1的触脚钩11被前套管4凸起42上的倾斜面45顶起。
第二阶段：
图18表示第二阶段的状态。从图18中可以看出，在此状态下，胰岛素笔继续旋入注射针头，尾盖1的触脚钩11越过前套管4凸起42，同时尾盖1的斜面12压迫前套管4上的弹 性卡榫41向内弯曲。
第三阶段：
图19和图20表示第三阶段的状态。在此状态下，胰岛素笔继续旋入注射针头，弹性卡榫41继续向内弯曲，最终迫使弹性卡榫41与第一卡榫台阶31脱钩并落入规避槽32，解除了前套管4在主壳体3内向前运动的限位，此时在弹簧7的推动下前套管4向前移动，直到凸起42被触脚钩11拦截而停止移动并对前套管4向前运动进行限位(见图19)。从图20中可以看出，在此状态下，外护套8上的卡块81卡入主壳体3的卡口38并伸入主壳体3内，针座2上的座盘23仍处于第一定位位置，而尾盖1渐渐接触针座2上的座盘23。
第四阶段：
图21、图22和图23表示第四阶段的状态。在此状态下，胰岛素笔继续旋入注射针头，尾盖1上的盖帽15抵靠针座2的座盘23并推动座盘23从第一定位位置向前移动至第二定位位置(见图21)，在第二定位位置上座盘23外缘及前后侧端面卡入主壳体3内缘上的卡槽34中配合形成卡锁定位结构，座盘23在第二定位位置上被锁定，既不能向前继续移动，也不能向后移动。在此状态下，由于触发管5前端顶靠在外护套8的前部内端面上，当针座2向前移动时，针座2上的凸部22与触发管5上的凹部51之间的定位被解锁(见图22)。在此状态下，座盘23外缘顶起外护套8上的卡块81，使卡块81与卡口38脱扣，导致外护套8与主壳体3解锁，在此状态下允许摘除外护套8(见图23)。
第五阶段：
图25和图26表示第五阶段的状态。在此状态下，用手摘除外护套8。
第六阶段：
图26表示第六阶段的状态。在此状态下，将触发管5与人体皮肤接触，针体6开始刺入人体皮肤。当触发管5的前端与人体皮肤接触时，触发管5向后移动，此时触发管5上的插头52顶起尾盖1上的挡块13，迫使尾盖1的触脚钩11与前套管4的凸起42渐渐分离。
第七阶段：
图27表示第七阶段的状态。在此状态下，触发管5继续向后移动，直到触脚钩11与凸起42完全分离后在弹簧7的推动下前套管4向前移动，并伸出主壳体3前端，前套管4的前端面受阻于人体皮肤，与触发管5前端面平齐并一起运动。
第八阶段：
图28表示第八阶段的状态。在此状态下，针体6完全进入人体皮肤后开始注射胰岛素。
第九阶段：
图29和图30表示第九阶段的状态。在此状态下，从人体皮肤拔出所述注射针头，此时前套管4被弹簧7推出主壳体3前端，直到前套管4上的凸起42被主壳体3上的第二卡榫台 阶35拦截而停止向前伸出，此时前套管4用来保护针体6的注射段(见图29)。在此状态下，前套管4的弹性尾翼43伸展后卡入主壳体3的防退槽36中形成前套管4向后移动的限位，防止前套管4回退(见图30)。
第十阶段：
图31表示第十阶段的状态。在此状态下，将胰岛素笔旋出注射针头，尾盖1在弹簧7推动下向后移动，同时尾盖1上的两个挡块13夹持住触发管5上的插头52，并带动触发管5向后移动。
使用后状态：
图32表示使用后状态。在此状态下，随着胰岛素笔不断旋出，触发管5继续向后移动直到针座2上的座杆24前端低靠触发管5前部内端面而停止。接着，尾盖1上的尖角卡榫14落入主壳体3的第三卡榫台阶37形成尾盖1向前移动的限位，而触发管5插头52的倒钩与两个挡块13配合，用来限制尾盖1在主壳体3后端内向后移动，此时尾盖1用来保护针体6的连接段，同时防止所述注射针头被二次使用。
从以上实施例中可以看出，本发明一次性安全型胰岛素注射针头中各个零部件结构之间的配合与其实现功能的关系如下：
1.在使用前状态下，有下列关系：
(1)外护套8的卡块81与主壳体3的卡口38配合，用于实现外护套8与主壳体3的锁定；
(2)针座2的凹沟21与主壳体3的凸筋33配合，用于实现针座2与主壳体3的定位(第一定位)；
(3)针座2的凸部22与触发管5的凹部51配合，用于实现触发管5与针座2的定位；
(4)前套管4的弹性卡榫41与主壳体3的第一卡榫台阶31配合，用于实现前套管4在主壳体3内向前运动的限位；
(5)前套管4的弹性卡榫41与尾盖1的触脚钩11配合，用于实现尾盖1相对前套管4向后运动的限位；
(6)弹簧7、尾盖1的挡块13与前套管4的内端面44之间的配合，其中，弹簧7一端抵靠在尾盖1的挡块13上，另一端抵靠在前套管4的内端面44，用于实现尾盖1、前套管4和弹簧7之间的连接和定位。
2.在使用中状态下，有下列关系：
(1)尾盖1的斜面12与前套管4的弹性卡榫41配合，用于解除前套管4在主壳体3内向前运动的限位。具体是：在使用中，随着尾盖1向前移动，斜面12压迫弹性卡榫41向内弯曲，最终迫使弹性卡榫41与第一卡榫台阶31脱钩，解除前套管4在主壳体3内向前运动的限位；
(2)尾盖1的触脚钩11与前套管4的凸起42配合，用于实现对前套管4向前运动进行限位。具体是：在使用中，随着胰岛素笔不断旋入注射针头，尾盖1向前移动，触脚钩11被凸起42斜面顶起，之后越过凸起42，并在弹性卡榫41与第一卡榫台阶31脱钩后，触脚钩11勾住凸起42对前套管4向前运动进行限位(凸起42在向前运动中被触脚钩11拦截)；
(3)针座2的座盘23与主壳体3的卡槽34配合，用于实现针座2与主壳体3的定位(第二定位)；
(4)前套管4的弹性卡榫41与主壳体3的规避槽32配合，用于避免弹性卡榫41对弹簧7的干涉。具体是：在使用中，弹性卡榫41越过主壳体3的第一卡榫台阶31后落入规避槽32中是为了避免弹性卡榫41对弹簧7的干涉(避免弹性卡榫41碰到弹簧7形成干涉)；
(5)尾盖1的盖帽15与针座2的座盘23配合，用于实现移动定位。具体是：在使用中，随着尾盖1向前移动，盖帽15渐渐接触座盘23，并推动座盘23挣脱上述第一定位，继续向前移动，直到落入第二定位后不能再动；
(6)针座2的座盘23、外护套8的卡块81与主壳体3的卡口38之间的配合，用来将是否允许摘除外护套8与胰岛素笔和注射针头是否准备好注射的状态关联起来。具体是：在使用中，当针座2上的座盘23落入主壳体3上的卡槽34时，首先，表明注射针头已正式安装到胰岛素笔头部；其次，座盘23的外缘顶起外护套8上的卡块81，使外护套8在发生变形，最终导致外护套8上的卡块81与主壳体3上的卡口38脱扣，从而实现外护套8与主壳体3的解锁，此时可以摘除外护套8；第三，由于触发管5前端抵靠在外护套8的内端面上，当针座2向前移动时，针座2上的凸部22与触发管5上的凹部51之间的定位被解锁，表明触发管5已进入可以触发的状态；
(7)触发管5的插头52与尾盖1的挡块13配合，用于解除前套管4向前移动的限位。具体是：当触发管5的前端与人体皮肤接触时，触发管5向后移动，此时触发管5上的插头52顶起尾盖1上的挡块13，迫使尾盖1的触脚钩11与前套管4的凸起42渐渐分离，直到完全分离后在弹簧7的作用下前套管4向前移动，并伸出主壳体3前端，前套管4的前端面受阻于人体皮肤，与触发管5前端面平齐并一起运动，直到针完全进入人体皮肤后开始注射胰岛素。
3.在使用后状态下，有下列关系：
(1)前套管4的凸起42与主壳体3的第二卡榫台阶35配合，用于实现前套管4从主壳体3向外伸出的限位(防止前套管4从主壳体3中滑出)；
(2)前套管4的弹性尾翼43与主壳体3的防退槽36配合，用于实现前套管4从主壳体3向内回退的限位(防止前套管4从主壳体3中回退)；
(3)尾盖1尖角卡榫14与主壳体3的第三卡榫台阶37配合，用来阻止尾盖1在主壳体3 内在外力作用下向前移动，防止针头二次使用。
实施例2：一次性安全胰岛素注射针头(带前端针尖保护，不带后端针尖保护)如图36所示，该注射针头由针体6、针座2、主壳体3、外护套8、前套管4、触发管5以及弹簧7。
在完全理解了实施例1胰岛素注射针头之后，实施例2与实施例1相比仅带有带前端针尖保护结构，不带有后端针尖保护结构。具体来说，在结构设计方面存在如下不同：
第一，实施例2取消了实施例1中的尾盖1；
第二，实施例2将实施例1尾盖1中的两个前腿16移植到实施例1针座2上，见图37所示。实施例2保留了前腿16上所设的挡块13和触脚钩11。实施例2取消了前腿16上所设的尖角卡榫14。
第三，实施例2由于取消了前腿16上所设的尖角卡榫14，所以对应取消了主壳体3筒体内壁后部设有第三卡榫台阶37。
第四，实施例2与实施例1相比由于在使用前装配状态下前腿16的位置发生了变化(比原来位置靠前向，已越过前套管4的凸起42)，所以对应取消了凸起42一侧的倾斜面45。
实施例2所述胰岛素注射针头的其余结构与实施例1完全相同，为了节省篇幅这理不再进行重复描述，本领域技术人员完全理解实施例1之后应容易理解实施例2。
实施例2胰岛素注射针头的使用过程简述如下：
如图38和39所示，在使用前装配状态下，外护套8套装在主壳体3外侧，外护套8上的卡块81卡入主壳体3的卡口38并伸入主壳体3内，使外护套8与主壳体3锁定连接；针座2和针体6位于主壳体3内，针座2上的座盘23处于主壳体3内第一定位位置，在第一定位位置上座盘23外缘圆周方向的凹沟21与主壳体3内缘上的凸筋33配合形成凹凸定位结构，座盘23上向前延伸的两个前腿16伸向前方；所述前套管4位于主壳体3内，前套管4上的弹性卡榫41卡在主壳体3上的第一卡榫台阶31上，限制前套管4相对主壳体3向前运动；所述触发管5位于主壳体3前端内并延伸至前端外，用于保护针体6的注射段，触发管5相对主壳体3设有向前移动的限位，触发管5的后部套装在针座2的座杆24上，触发管5的后部位于前套管4内，触发管5处于第三定位位置上，触发管5的前端接近或顶靠在外护套8的前部内端面上，触发管5上的凹部51卡在座杆24的凸部22上形成定位，此时，针座2上的座盘23相对主壳体3处于第一定位位置上；所述弹簧7一端抵靠在针座2两个前腿16的挡块13上，另一端抵靠在前套管4的内端面44上。
如图40和41所示，在使用中，当使用者将胰岛素笔头部旋入本实施例所述注射针头时，胰岛素笔的头部推动座盘23向前移动，前腿16内侧的斜面12压迫弹性卡榫41向 内弯曲，最终迫使弹性卡榫41与第一卡榫台阶31脱钩并落入规避槽32，解除前套管4在主壳体3内向前运动的限位，此时在弹簧7的推动下前套管4向前移动，直到凸起42被触脚钩11拦截而停止移动并对前套管4向前运动进行限位；与此同时，座盘23从第一定位位置向前移动至第二定位位置，在第二定位位置上座盘23外缘及前后侧端面卡入主壳体3内缘上的卡槽34中配合形成卡锁定位结构，座盘23在第二定位位置上被锁定，既不能向前继续移动，也不能向后移动。在此状态下，由于触发管5前端顶靠在外护套8的前部内端面上，当针座2向前移动时，针座2上的凸部22与触发管5上的凹部51之间的第三定位被解锁，此时触发管5与座杆24形成滑动连接。同时，在此状态下，座盘23外缘顶起外护套8上的卡块81，使卡块81与卡口38脱扣，导致外护套8与主壳体3解锁，在此状态下摘除外护套8。接着，将触发管5与人体皮肤接触，针体6开始刺入人体皮肤，触发管5向后移动，此时触发管5上的插头52顶起前腿16上的挡块13，迫使前腿16的触脚钩11与前套管4的凸起42渐渐分离，直到完全分离后在弹簧7的推动下前套管4向前移动，并伸出主壳体3前端，前套管4的前端面受阻于人体皮肤，与触发管5前端面平齐并一起运动，直到针完全进入人体皮肤后开始注射胰岛素。
如图42和43所示，在使用后从人体皮肤拔出所述注射针头时，前套管4被弹簧7推出主壳体3前端，直到前套管4上的凸起42被主壳体3上的第二卡榫台阶35拦截而停止向前伸出，此时前套管4用来保护针体6的注射段；同时前套管4的弹性尾翼43伸展后卡入主壳体3的防退槽36中形成前套管4向后移动的限位，防止前套管4回退，最后从所述胰岛素笔头部拆除所述注射针头。
以上实施例中的有关内容和变化说明如下：
1.以上两个实施例中，所述第一定位结构采用的是凹凸定位结构，除此而外可以采用弹性定位结构或者摩擦定位结构来替换，也可获得相同或相似的技术效果，这是本领域技术人员可理解的。从理论上讲第一定位结构应采用非锁死性质的定位结构，因为在使用前座盘23外缘与主壳体3内缘处于第一定位位置，而使用中座盘23外缘与主壳体3内缘之间需要轴向滑动。
所述弹性定位结构由弹性珠销与凹陷配合形成，弹性珠销和凹陷两者中，一者设在座盘23外缘上，另一者设在主壳体3内缘上。
所述摩擦定位结构由座盘23外缘与主壳体3内缘摩擦配合形成。
2.以上两个实施例中，所述第二定位结构采用的卡锁定位结构，除此而外可以采用弹性定位结构、摩擦定位结构或者端面抵靠定位结构来替换，也可获得相同或相似的技术效果，这是本领域技术人员可理解的。从理论上讲第二定位结构可以采用非锁死性质的定位结构，也可以采用锁死性质的定位结构。弹性定位结构、摩擦定位结构或者端面抵靠定 位结构应属于非锁死性质的定位结构，而以上实施例中，由座盘23外缘及前后侧端面与主壳体3内缘上所设的卡槽34配合形成的卡锁定位结构应属于锁死性质的定位结构。但是在这种卡锁定位结构中，当卡槽34的宽度大于座盘23厚度时就存在间隙，当这种间隙大到一定程度座盘23便可以在卡槽34中来回滑动，从而转化成非锁死性质的定位结构。
所述端面抵靠定位结构由座盘23外缘的前侧端面与主壳体3内缘的内端面抵靠配合形成。
3.以上两个实施例中，所述卡口38在主壳体3轴向位于第二定位位置上，实际上卡口38的位置只要在第二定位位置上或者第二定位位置附近均可以获得相同或相似的技术效果。所述附近是指以第二定位位置为基点靠前方一点或靠后方一点。在本发明中这样的位置关系是为了满足特定关系而设定的，这种特定关系是：当座盘23从第一定位位置移动至第二定位位置时，座盘23外缘顶起外护套8上的卡块81，使外护套8发生变形，最终导致卡块81与卡口38脱扣，从而实现外护套8与主壳体3解锁，最终将是否允许摘除外护套8与胰岛素笔和注射针头是否准备好注射的状态关联起来。
4.以上两个实施例中，所述触发管5相对主壳体3设有向前移动的限位由触发管5的前端接近或顶靠在外护套8的前部内端面上形成。为了实现对触发管5向前移动的限位还可以采用其他结构形式，比如参见附图33-图35所示，触发管5的挡台53顶靠在前套管4的前部内端面44上的卡台46上形成触发管5相对主壳体3设有向前移动的限位。
5.以上两个实施例是为了说明本发明技术方案而给出的一个实例，从本发明背景技术介绍以及需要解决的技术问题和发明目的来看，主要涉及针座2、主壳体3、外护套8和触发管5及其他们之间的结构和连接关系，与尾盖1、前套管4以及弹簧7关联不大。换句话说，尾盖1、前套管4以及弹簧7对于本发明来说属于非必要结构，可以允许他们发生一些变化，比如，省去用于保护针体2连接段的尾盖1；将本发明的技术方案应用于背景技术介绍的中国专利CN101563124A中；将本发明的技术方案应用于美国专利US2011/0288491A1中等等。
上述实施例只为说明本发明的技术构思及特点，其目的在于让熟悉此项技术的人士能够了解本发明的内容并据以实施，并不能以此限制本发明的保护范围。凡根据本发明精神实质所作的等效变化或修饰，都应涵盖在本发明的保护范围之内。

Claims (10)

  1. 一种一次性安全胰岛素注射针头，包括：
    针体(6)，该针体(6)具有一个向前端方向延伸的注射段、一个向后端方向延伸的连接段和一个位于注射段和连接段之间的固定段；
    针座(2)，该针座(2)用于固定针体(6)，所述针体(6)的固定段固定在针座(2)上，针体(6)的注射段从针座(2)前端伸出，针体(6)的连接段从针座(2)后端伸出；
    主壳体(3)，该主壳体(3)为筒体结构，在装配状态下针座(2)和针体(6)位于主壳体(3)内，主壳体(3)的后端用于连接胰岛素笔；
    触发管(5)，该触发管(5)的主体结构为管体，在使用前装配状态下触发管(5)位于主壳体(3)前端内并延伸至前端外，用于保护针体(6)的注射段；
    其特征在于：
    所述针座(2)由座盘(23)和座杆(24)组成，座杆(24)位于座盘(23)前端并与座盘(23)固定连接；座盘(23)的外缘与主壳体(3)的内缘相配合，对应座盘(23)外缘在主壳体(3)内缘上沿轴向间隔设有第一定位位置和第二定位位置，在所述注射针头安装到所述胰岛素笔的过程中，利用胰岛素笔头部对针座(2)产生的轴向推力迫使座盘(23)在主壳体(3)内从第一定位位置沿轴向向前移动至第二定位位置，从而使针座(2)与主壳体(3)之间形成滑动定位的连接关系；在第一定位位置上座盘(23)的外缘与主壳体(3)的内缘通过第一定位结构进行配合，在第二定位位置上座盘(23)的外缘与主壳体(3)的内缘通过第二定位结构进行配合；所述第一定位结构采用凹凸定位结构、弹性定位结构或者摩擦定位结构；所述第二定位结构采用凹凸定位结构、弹性定位结构、摩擦定位结构、卡锁定位结构或者端面抵靠定位结构；
    所述触发管(5)相对主壳体(3)设有向前移动的限位，触发管(5)的后部套装在针座(2)的座杆(24)上；触发管(5)管体与座杆(24)之间一侧设有凹部(51)，另一侧设有凸部(22)，凹部(51)卡在凸部(22)上形成第三定位，当触发管(5)相对座杆(24)处于第三定位位置时，针座(2)上的座盘(23)相对主壳体(3)处于第一定位位置上；当座盘(23)在主壳体(3)内从第一定位位置沿轴向向前移动至第二定位位置时，触发管(5)与座杆(24)解除第三定位，并形成滑动连接。
  2. 根据权利要求1所述的注射针头，其特征在于：所述主壳体(3)外设有外护套(8)，该外护套(8)为套筒结构，在使用前装配状态下外护套(8)套装在主壳体(3)外侧，用于保护所述注射针头整体；所述触发管(5)相对主壳体(3)设有向前移动的限位由触发管(5)的前端接近或顶靠在外护套(8)的前部内端面上形成。
  3. 根据权利要求1所述的注射针头，其特征在于：所述凹凸定位结构由设在座盘(23) 外缘圆周方向的凹沟(21)与设在主壳体(3)内缘上的凸筋(33)配合形成。
  4. 根据权利要求1所述的注射针头，其特征在于：所述弹性定位结构由弹性珠销与凹陷配合形成，弹性珠销和凹陷两者中，一者设在座盘(23)外缘上，另一者设在主壳体(3)内缘上。
  5. 根据权利要求1所述的注射针头，其特征在于：所述摩擦定位结构由座盘(23)外缘与主壳体(3)内缘摩擦配合形成。
  6. 根据权利要求1所述的注射针头，其特征在于：所述卡锁定位结构由座盘(23)外缘及前后侧端面与主壳体(3)内缘上所设的卡槽(34)配合形成。
  7. 根据权利要求1所述的注射针头，其特征在于：所述端面抵靠定位结构由座盘(23)外缘的前侧端面与主壳体(3)内缘的内端面抵靠配合形成。
  8. 8.根据权利要求2所述的注射针头，其特征在于：所述主壳体(3)筒体侧壁上设有卡口(38)，卡口(38)在主壳体(3)轴向上对应第二定位位置布置，该卡口(38)为一个贯穿主壳体(3)内外壁之间的通孔，对应该通孔在外护套(8)套筒内壁上设有卡块(81)，在外护套(8)套装主壳体(3)状态下卡块(81)卡入卡口(38)并伸入主壳体(3)内，使外护套(8)与主壳体(3)锁定连接；当座盘(23)从第一定位位置移动至第二定位位置时，座盘(23)外缘顶起外护套(8)上的卡块(81)，使外护套(8)发生变形，最终导致卡块(81)与卡口(38)脱扣，从而实现外护套(8)与主壳体(3)解锁，在此状态下允许摘除外护套(8)。
  9. 根据权利要求8所述的注射针头，其特征在于：所述外护套(8)的套筒内壁上沿轴向设有向内突出的筋条(82)，当外护套(8)套装在主壳体(3)外侧后，外护套(8)内壁与主壳体(3)外壁之间留有供外护套(8)发生变形的间隙。
  10. 根据权利要求8所述的注射针头，其特征在于：所述主壳体(3)的卡口(38)处设有向前端方向延伸的滑槽(39)，以有利于卡块(81)与卡口(38)脱离。
PCT/CN2016/078193 2015-04-28 2016-03-31 一次性安全胰岛素注射针头 WO2016173383A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201510208107.XA CN104771813B (zh) 2015-04-28 2015-04-28 一次性安全胰岛素注射针头
CN201510208107.X 2015-04-28

Publications (1)

Publication Number Publication Date
WO2016173383A1 true WO2016173383A1 (zh) 2016-11-03

Family

ID=53613780

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/078193 WO2016173383A1 (zh) 2015-04-28 2016-03-31 一次性安全胰岛素注射针头

Country Status (2)

Country Link
CN (1) CN104771813B (zh)
WO (1) WO2016173383A1 (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104771814B (zh) * 2015-04-28 2017-11-21 苏州施莱医疗器械有限公司 一次性安全型胰岛素注射针头
CN104771813B (zh) * 2015-04-28 2017-08-22 苏州施莱医疗器械有限公司 一次性安全胰岛素注射针头
JP2019509075A (ja) * 2015-12-15 2019-04-04 イインジェック テクノロジーズ インコーポレイテッド／レ テクノロジーズ イインジェック インコーポレイテッド 引き込み可能な針を備える注射器
CN106389123B (zh) * 2016-10-21 2019-01-15 浙江瑞邦智能装备股份有限公司 一种新型注射器
CN107469188B (zh) * 2017-08-03 2023-04-18 安徽迈菲思医疗器械有限公司 一种安全针
CN107823761B (zh) * 2017-12-08 2023-08-18 宁波美生医疗器材有限公司 一种安全胰岛素笔配套用针
CN108543169B (zh) * 2018-05-16 2023-12-01 普昂(杭州)医疗科技股份有限公司 一种安全式胰岛素笔针
CN108992745B (zh) * 2018-06-29 2020-11-03 苏州沙力医疗器械有限公司 转动锁定式安全胰岛素注射针头
WO2020019154A1 (zh) * 2018-07-24 2020-01-30 江苏采纳医疗科技有限公司 一种一次性使用防针刺胰岛素注射笔针及防针刺方法
WO2021168781A1 (zh) * 2020-02-28 2021-09-02 江苏采纳医疗科技有限公司 一种安全胰岛素笔针
CN111658896B (zh) * 2020-06-18 2020-12-15 普昂(杭州)医疗科技有限公司 一种自动触发式针头保护装置及胰岛素笔针
WO2022078237A1 (zh) * 2020-10-12 2022-04-21 普昂(杭州)医疗科技股份有限公司 针保护结构、保护方法及针装置
CN112155565B (zh) * 2020-10-12 2021-07-23 普昂(杭州)医疗科技股份有限公司 针保护结构及针装置

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2619583Y (zh) * 2003-04-24 2004-06-09 施国平 自锁型一次性安全自动采血针
CN101594899A (zh) * 2006-09-06 2009-12-02 特克法马许可公司 具有封锁住的保护位置的针保护装置
CN101945680A (zh) * 2008-01-15 2011-01-12 贝克顿·迪金森公司 具有针插入机构的笔针组件
US20130245562A1 (en) * 2010-11-29 2013-09-19 Sanofi-Aventis Deutschland Gmbh Automatic Delivery Device with Triggering Mechanism
CN104307072A (zh) * 2014-10-29 2015-01-28 杭州普昂医疗科技有限公司 安全式胰岛素笔针
CN104771813A (zh) * 2015-04-28 2015-07-15 苏州施莱医疗器械有限公司 一次性安全胰岛素注射针头
CN104771814A (zh) * 2015-04-28 2015-07-15 苏州施莱医疗器械有限公司 一次性安全型胰岛素注射针头
CN104771815A (zh) * 2015-04-28 2015-07-15 苏州施莱医疗器械有限公司 带针尖保护的胰岛素注射针头
CN204995930U (zh) * 2015-04-28 2016-01-27 苏州施莱医疗器械有限公司 一次性安全型胰岛素注射针头
CN204995929U (zh) * 2015-04-28 2016-01-27 苏州施莱医疗器械有限公司 带针尖保护的胰岛素注射针头
CN205007385U (zh) * 2015-04-28 2016-02-03 苏州施莱医疗器械有限公司 一次性安全胰岛素注射针头

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2619583Y (zh) * 2003-04-24 2004-06-09 施国平 自锁型一次性安全自动采血针
CN101594899A (zh) * 2006-09-06 2009-12-02 特克法马许可公司 具有封锁住的保护位置的针保护装置
CN101945680A (zh) * 2008-01-15 2011-01-12 贝克顿·迪金森公司 具有针插入机构的笔针组件
US20130245562A1 (en) * 2010-11-29 2013-09-19 Sanofi-Aventis Deutschland Gmbh Automatic Delivery Device with Triggering Mechanism
CN104307072A (zh) * 2014-10-29 2015-01-28 杭州普昂医疗科技有限公司 安全式胰岛素笔针
CN104771813A (zh) * 2015-04-28 2015-07-15 苏州施莱医疗器械有限公司 一次性安全胰岛素注射针头
CN104771814A (zh) * 2015-04-28 2015-07-15 苏州施莱医疗器械有限公司 一次性安全型胰岛素注射针头
CN104771815A (zh) * 2015-04-28 2015-07-15 苏州施莱医疗器械有限公司 带针尖保护的胰岛素注射针头
CN204995930U (zh) * 2015-04-28 2016-01-27 苏州施莱医疗器械有限公司 一次性安全型胰岛素注射针头
CN204995929U (zh) * 2015-04-28 2016-01-27 苏州施莱医疗器械有限公司 带针尖保护的胰岛素注射针头
CN205007385U (zh) * 2015-04-28 2016-02-03 苏州施莱医疗器械有限公司 一次性安全胰岛素注射针头

Also Published As

Publication number Publication date
CN104771813A (zh) 2015-07-15
CN104771813B (zh) 2017-08-22

Similar Documents

Publication Publication Date Title
WO2016173383A1 (zh) 一次性安全胰岛素注射针头
WO2016173384A1 (zh) 带针尖保护的胰岛素注射针头
WO2016173367A1 (zh) 一次性安全型胰岛素注射针头
JP5475688B2 (ja) 挿入注射針を備えるペン型注射針組立体
JP4937139B2 (ja) 医療用針のための安全装置
US5433712A (en) Self-sheathing hypodermic syringe
AU2004286735B2 (en) Autoinjection device
JP5492902B2 (ja) 引込み可能な針を具えるユニバーサルシリンジ
US5295965A (en) Automatic injectors
TWI568468B (zh) 藥物輸送裝置
EP2723427B1 (en) Syringe safety assembly
TW201642918A (zh) 注射裝置
CA2127359C (en) Automatic injectors
US20100185147A1 (en) Disposable safety syringe structure
AU2004269838A1 (en) Device for administering an injectable product, comprising an anti-release safety device
JP2009515609A (ja) プランジャ係止手段を具える安全注射器
AU2014237446A1 (en) Palm activated drug delivery device
JP2014502889A (ja) 自動注射器の前部
WO2020001656A1 (zh) 转动锁定式安全胰岛素注射针头
US20230241312A1 (en) Subcutaneous infusion needle stick prevention device using needle hub retraction
EP3077027B1 (en) A safety clip
US11260173B2 (en) Needle assembly for subcutaneous infusion set
TW201711715A (zh) 安全針組
CN219375719U (zh) 一种手动锁定的胰岛素注射针头
JP2002345958A (ja) ロールケーシング制御式引戻し安全注射器

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16785814

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16785814

Country of ref document: EP

Kind code of ref document: A1